Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daiichi Biotech Services is a private Malaysian healthcare products and diagnostics company focused on integrated healthcare solutions rather than therapeutic drug development. The company markets and distributes in vitro diagnostics, laboratory quality controls, G6PD reagent kits, blood collection products, and related medical devices and consumables. It is licensed in Malaysia to import and distribute registered electromechanical medical devices, IVD devices, and single-use devices, and it positions itself around disease detection, screening, evaluation, and monitoring. Based on the available public information, Daiichi Biotech Services appears to operate as a commercial diagnostics and medical products supplier, not as a clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daiichi Biotech.